Medication info
Jemiro Optional 50/5 mg

Jemiro Optional 50/5 mg

Prescription medicationTabletOral
Ingredient · strength
Gemigliptin Tartrate Sesquihydrate›68.9mg / 1 tabletRosuvastatin Calcium Micronized›5.2mg / 1 tablet
Manufacturer / importer
LG Chemical Co., Ltd.
Appearance
Light green round film-coated tablet
Packaging
56 tablets (14 tablets/PTP x 4), 28 tablets (14 tablets/PTP x 2)
Approval status
Active

MFDS item code 201706396 · Approved 2017.07.31 · Insurance code 668903190

Summary

Main use
Alternative combination therapy for patients receiving gemigliptin and rosuvastatin concomitantly
Who takes it
Adults
Adult dose
This medicine is for use in adults only. For convenience, patients taking gemigliptin and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) and take it once daily.

Ingredients

Manufacturer
LG Chemical Co., Ltd.

Efficacy & effects

Alternative combination therapy for patients receiving gemigliptin and rosuvastatin concomitantly

View approved original text

This medication is used as a combination replacement therapy for patients who need to take both gemigliptin tartrate and rosuvastatin calcium simultaneously. In other words, if these two medications need to be administered together, treatment can be carried out using this medication.

How to take

Adult dose

This medicine is for use in adults only. For convenience, patients taking gemigliptin and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) and take it once daily.

Precautions

This medication should not be administered to certain patients. For instance, it should not be used in individuals who are allergic to this medication or its components, those with certain types of diabetes, liver diseases, muscular disorders, severe kidney dysfunction, or women who are pregnant or breastfeeding. Additionally, caution should be exercised when administering this medication to patients taking sulfonylureas, patients with heart failure, liver dysfunction, or a history of acute pancreatitis. If symptoms of muscle pain or myopathy occur, consultation with a physician should be sought immediately. This medication contains lactose, and therefore patients with lactose intolerance should not take it. Caution is also needed for elderly patients or those with certain genetic predispositions. While taking this medication, liver function and muscle condition should be regularly monitored; if any abnormal symptoms are detected, treatment must be stopped immediately and instructions from a physician should be followed. This medication may interact with other drugs, so if other medications are being taken, it is essential to inform healthcare providers, particularly if strong metabolic enzyme inducers or inhibitors, or fibrate drugs are combined. Women of childbearing potential should use appropriate contraceptive methods, and this medication should not be used during pregnancy or breastfeeding. Moreover, in case of overdose, since there are no specific antidotes, immediate medical assistance should be sought, and as this medication can cause dizziness, caution should be exercised when driving or operating machinery. Finally, this medication has not been confirmed to be safe and effective for children and adolescents under 18 years of age, and should not be administered to them.

Side effects

Diarrhea, indigestion, gastritis, pharyngitis, hyperglycemia, musculoskeletal pain, facial paralysis, ear and labyrinth disorders, sudden hearing loss, muscle spasms, cholelithiasis, polyuria, arthralgia, bacteriuria, upper respiratory infection, increased serum amylase levels, increased lipase levels, fever, urinary tract infection, hypoglycemia, dizziness, nausea, constipation, headache, back pain, increased serum CPK levels, asthenia, myalgia, vesicular pemphigoid, acute pancreatitis, chronic obstructive pulmonary disease, asthma exacerbation, dyspnea, fatigue, chest pain, angina, soft tissue infection, thrombocytopenia, intracranial hemorrhage, systemic weakness, gastrointestinal air retention, gastric ulcer, gingival swelling, dental diseases, periodontitis, multifocal neuropathy, sensory abnormalities, eye twitching, neuralgia, spinal canal stenosis, sputum-related diseases, sinusitis, rash, fungal dermatitis, eczema, urticaria, seborrheic dermatitis, skin diseases, hepatitis, increased gamma-GT, fatty liver, electrolyte imbalance, skeletal pain, osteoporosis, osteoarthritis, ligament disorders, cystitis, increased serum creatinine, acute renal failure, proteinuria, neurogenic bladder, urethral stricture, motion sickness, unspecified ear disease, tinnitus, glaucoma, allergic conjunctivitis, loss of appetite, anemia, folate deficiency, iron deficiency anemia, palpitations, arrhythmia, exacerbation of hypertension, increased blood pressure, insomnia, increased ALT, increased AST, pruritus, myopathy, rhabdomyolysis, hematuria, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, syncope, body pain, muscle cramps, gout, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a special container that does not allow light to pass through. Additionally, it is important to store it at a temperature between 1 to 30 degrees Celsius to maintain the efficacy of the medication.

Appearance and packaging

Appearance

Light green round film-coated tablet

Package unit

56 tablets (14 tablets/PTP x 4), 28 tablets (14 tablets/PTP x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.